-
Forest to make late decision on Gibbs-White fitness for Villa Europa semi
-
Malian singer Rokia Traore gets suspended jail in Belgian custody case
-
Disney shares jump after results top expectations
-
Cruise ship passenger with hantavirus being treated in Zurich
-
Ryanair's O'Leary urges pre-flight morning booze ban
-
Ghana artist's billboard campaign takes aim at fast fashion fallout
-
Hopes rise for Iran deal as US halts guiding ships in Hormuz
-
Biogas helps cut bills, deforestation in east DR Congo
-
Protests as Venice Biennale opens in turmoil over Russian presence
-
Zelensky says Russia choosing war as dual ceasefires falter
-
Paris gets taste of Nigeria's Nollywood
-
Simeone, Atletico at crossroads after Arsenal Champions League KO
-
Indonesia eyes e-commerce ban for under-16s: minister to AFP
-
Three evacuated from hantavirus-hit cruise ship
-
US pauses guiding ships through Hormuz, cites Iran deal hopes
-
Venezuela to ICJ: Rights to oil-rich region 'inalienable'
-
Former Russian insider says fear pushed elites to embrace Putin war
-
Evacuations 'ongoing' from hantavirus-hit cruise ship
-
Oil tumbles and stocks rally on peace hopes, Samsung tops $1 trillion
-
Asia football fans sweat on broadcast rights as World Cup nears
-
US pauses Hormuz escorts, Trump says progress on Iran deal
-
Cambodian PM's cousin says owned 30% of scam-linked firm
-
Hegseth's church brings its Christian nationalism to Washington
-
Afrobeats' Tiwa Savage nurtures Africa's future talent
-
Venice Biennale opens in turmoil over Russian presence
-
Philips profits double in first quarter
-
Strasbourg on verge of European final amid fan displeasure at owners BlueCo
-
Tradition, Trump and tennis: Five things about Pope Leo
-
100 years on Earth: Iconic naturalist Attenborough marks century
-
Bondi Beach mass shooting accused faces 19 extra charges
-
Ukraine reports strike as Kyiv's ceasefire due to begin
-
Australia says 13 citizens linked to alleged IS members returning from Syria
-
Thunder overpower Lakers, Pistons down Cavs
-
Boycott-hit 70th Eurovision celebrated under high security
-
Court case challenges New Zealand's 'magical thinking' climate plans
-
Iran war jolts China's well-oiled manufacturing hub
-
Oil sinks and stocks rally on peace hopes, Samsung tops $1 trillion
-
Infantino defends World Cup ticket prices
-
Pistons hold off Cavs to win series-opener
-
Rubio rising? Duel with Vance for 2028 heats up
-
Teen shooter kills two at Brazil school
-
US pauses Hormuz escorts in bid for deal, as threats continue
-
Judge orders German car-ramming suspect to psychiatric hospital
-
Fresh UAE attacks blamed on Iran draw new reality in the Gulf
-
Global Sports Brand U.S. Polo Assn. Delivers Record $2.7 Billion in Retail Sales for 2025, Targets $4 Billion and 1,500 U.S. Polo Assn. Stores
-
Transoft Solutions Acquires CADaptor Solutions
-
Arsenal on cusp of history after reaching Champions League final
-
Trump says pausing Hormuz operation in push for Iran deal
-
Wembanyama accused of 'obvious' illegal blocking
-
Musk 'was going to hit me,' OpenAI executive says at trial
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
S.Spengler--VB